Merck spends $10 billion for Verona, gaining access to its COPD medication
By MICHELLE CHAPMAN Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. Related Articles Customers seeking deals gave Amazon’s Prime Day and competing sales a solid start Could renting … Continued